Central Pharmaceutical Joint Stock Company No3 (HNX: DP3)

Market Cap	1.24T
Revenue (ttm)	417.49B
Net Income (ttm)	121.17B
Shares Out	21.50M
EPS (ttm)	5,636.00
PE Ratio	10.20
Forward PE	n/a
Dividend	3,000.00 (5.22%)
Ex-Dividend Date	Mar 21, 2024

Volume	4,504
Average Volume	12,055
Open	57,500
Previous Close	57,500
Day's Range	56,900 - 57,500
52-Week Range	57,500 - 77,000
Beta	0.36
RSI	53.92
Earnings Date	Jan 16, 2025

About HNX: DP3

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturin...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DP3

Financial Performance

In 2024, DP3's revenue was 417.49 billion, an increase of 1.89% compared to the previous year's 409.73 billion. Earnings were 121.17 billion, a decrease of -3.27%.